Tokyo, Japan

Ippei Sato

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 10.4

ph-index = 3

Forward Citations = 28(Granted Patents)


Location History:

  • Tsukuba, JP (2006 - 2007)
  • Chuo-ku, JP (2014 - 2016)
  • Tokyo, JP (2015 - 2022)

Company Filing History:


Years Active: 2006-2022

where 'Filed Patents' based on already Granted Patents

10 patents (USPTO):

Title: Innovations of Ippei Sato

Introduction

Ippei Sato is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on tetrahydroisoquinoline derivatives. With a total of 10 patents to his name, Sato's inventions are paving the way for advancements in medical treatments.

Latest Patents

Sato's latest patents focus on novel tetrahydroisoquinoline derivative compounds. These compounds are disclosed as potential active ingredients for pharmaceutical compositions. They are particularly useful for preventing or treating diseases that respond to the modulation of the contractility of the skeletal sarcomere. The modulation can be achieved through the troponin complex of the fast skeletal muscle sarcomere, involving components such as fast skeletal myosin, actin, tropomyosin, troponin C, troponin I, and troponin T. The applications of these compounds include treating neuromuscular disorders, voluntary muscle disorders, CNS disorders characterized by muscle weakness and fatigue, muscle symptoms from systemic disorders, and dysfunctions of pelvic floor and urethral/anal sphincter muscles.

Career Highlights

Throughout his career, Sato has worked with notable companies in the pharmaceutical industry. He has been associated with Astellas Pharma GmbH and Cytokinetics, Inc. His work in these organizations has contributed to his expertise and the development of his patented innovations.

Collaborations

Sato has collaborated with several professionals in his field, including Masanori Miura and Takashi Kamikubo. These collaborations have likely enhanced the quality and impact of his inventions.

Conclusion

Ippei Sato's contributions to the field of pharmaceuticals through his innovative patents on tetrahydroisoquinoline derivatives demonstrate his commitment to advancing medical science. His work has the potential to significantly improve treatments for various muscle-related disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…